Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies

[1]  D. Werring,et al.  Longer term stroke risk in intracerebral haemorrhage survivors , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[2]  P. Rothwell,et al.  Ten-year risks of recurrent stroke, disability, dementia and cost in relation to site of primary intracerebral haemorrhage: population-based study , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[3]  V. Feigin,et al.  Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017 , 2020, Neuroepidemiology.

[4]  G. Lip,et al.  Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study , 2019, Cerebrovascular Diseases.

[5]  Ashutosh Kumar Singh,et al.  Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial , 2019, The Lancet. Neurology.

[6]  Ashutosh Kumar Singh,et al.  Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial , 2019, Lancet.

[7]  D. Leys,et al.  Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage , 2019, Stroke.

[8]  Eric E. Smith,et al.  Immunotherapy with ponezumab for probable cerebral amyloid angiopathy , 2019, Annals of clinical and translational neurology.

[9]  H. Huttner,et al.  Management of oral anticoagulation after intracerebral hemorrhage , 2019, International journal of stroke : official journal of the International Stroke Society.

[10]  Jinkwon Kim,et al.  Effect of Adherence to Antihypertensive Medication on the Long-Term Outcome After Hemorrhagic Stroke in Korea , 2018, Hypertension.

[11]  C. Sudlow,et al.  The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study , 2018, The Lancet Neurology.

[12]  Jason P Fine,et al.  Practical recommendations for reporting Fine‐Gray model analyses for competing risk data , 2017, Statistics in medicine.

[13]  Eric E. Smith,et al.  Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds , 2017, Neurology.

[14]  J. Hewitt,et al.  Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study , 2017, Trials.

[15]  D. Werring,et al.  The Cerebral Haemorrhage Anatomical RaTing inStrument (CHARTS): Development and assessment of reliability , 2017, Journal of the Neurological Sciences.

[16]  Sally Hopewell,et al.  Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis , 2016, British Medical Journal.

[17]  N. Townsend,et al.  Trends in the epidemiology of cardiovascular disease in the UK , 2016, Heart.

[18]  S. Greenberg,et al.  Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage. , 2015, JAMA.

[19]  C. Sudlow,et al.  Influence of Intracerebral Hemorrhage Location on Incidence, Characteristics, and Outcome: Population-Based Study , 2015, Stroke.

[20]  D. Werring,et al.  Variation in Restarting Antithrombotic Drugs at Hospital Discharge After Intracerebral Hemorrhage , 2014, Stroke.

[21]  Michael Tin Chung Poon,et al.  Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  C. Derdeyn,et al.  Independent Validation of the Secondary Intracerebral Hemorrhage Score With Catheter Angiography and Findings of Emergent Hematoma Evacuation , 2012, Neurosurgery.

[23]  C. Lau,et al.  Use of aspirin in Chinese after recovery from primary intracranial haemorrhage , 2011, Thrombosis and Haemostasis.

[24]  H. Diener,et al.  Recurrent Stroke after Lobar and Deep Intracerebral Hemorrhage: A Hospital-Based Cohort Study , 2011, Cerebrovascular Diseases.

[25]  Ale Algra,et al.  Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis , 2010, The Lancet Neurology.

[26]  M. Woodward,et al.  Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial , 2010, Stroke.

[27]  B. Norrving,et al.  Three-Year Survival and Stroke Recurrence Rates in Patients With Primary Intracerebral Hemorrhage , 2009, Stroke.

[28]  L. Forthun,et al.  Final Results , 2009 .

[29]  P. Rothwell,et al.  Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study , 2007, The Lancet Neurology.

[30]  T. Wilkinson,et al.  The risk of recurrent stroke after intracerebral haemorrhage , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[31]  Eric E. Smith,et al.  Antiplatelet use after intracerebral hemorrhage , 2006, Neurology.

[32]  T. Inagawa.  Recurrent primary intracerebral hemorrhage in Izumo City, Japan. , 2005, Surgical neurology.

[33]  P. Rothwell,et al.  External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.

[34]  S. Gutnikov,et al.  Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study) , 2004, The Lancet.

[35]  M. Woodward,et al.  Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial , 2003, Stroke.

[36]  P. Sandercock,et al.  Very Early Risk of Stroke After a First Transient Ischemic Attack , 2003, Stroke.

[37]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[38]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[39]  P. Austin,et al.  Rate of stroke recurrence in patients with primary intracerebral hemorrhage. , 2000, Stroke.

[40]  N. Battistini,et al.  Recurrence of bleeding in patients with primary intracerebral hemorrhage. , 1995, Stroke.

[41]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[42]  S M Nazarian,et al.  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.

[43]  Lippincott Williams Wilkins,et al.  Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.